DRKS00031101招募中不适用
Cardio- and nephroprotective mechanisms of SGLT2 inhibition
niversitätsklinikum Regensburg, Klinik und Poliklinik für Innere Medizin II0 个研究点目标入组 383 人开始时间: 2023年1月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 383
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Symptomatic heart failure
- •- nt-pro-BNP > 125 pg/mL
- •- Chronic renal failure stage G3a-G4 (GFR 15-59 mL/min)
- •- No or only mild albuminuria: UACR < 100 mg/g
排除标准
- •- Pre-existing therapy with SGLT2 inhibitor (SGLT2i)
- •- Severe symptomatic lung disease
- •- Autoimmune diseases
- •- Higher grade valvular disease
- •- Anemia (hemoglobin < 10 mg/dL)
- •- Uncontrolled hypertension
- •o Systolic blood pressure > 150 mmHg or
- •o Diastolic blood pressure > 100 mgHg or
- •o > 3 antihypertensive medications.
研究者
相似试验
招募中
不适用
Investigation of renal protective effects of SGLT2 inhibitor by using renal doppler ultrasonographyJPRN-UMIN000028438Ogawa Red Cross Hospital60
进行中（未招募）
1 期
The RECEDE-CHF TrialType 2 diabetes and heart failureMedDRA version: 20.0Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849MedDRA version: 20.0Level: LLTClassification code 10010684Term: Congestive heart failureSystem Organ Class: 100000004849MedDRA version: 20.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849MedDRA version: 20.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2016-003968-39-GBniversity of Dundee/NHS Tayside23
招募中
2 期
Comparison of the renoprotective effects of SGLT2 inhibitor (Empagliflozin) in diabetic and non-diabetic kidney transplantation patientsIRCT20130812014333N168Kermanshah University of Medical Sciences28
已完成
4 期
Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis PatientsSLESGLT2 InhibitorsLupus NephritisNCT05748925Mansoura University84
Unknown
4 期
Effect of SGLT2 inhibitor on Renal Function and Urinary [TIMP-2] x [IGFBP7] in Patients Hospitalized for Acute Heart Failure; A Randomized Controlled TrailAcute kidney injury and urinary [TIMP-2] x [IGFBP7] in patient hospitalized for acute heart failureAcute kidney injury, urinary [TIMP-2] x [IGFBP7], nephrocheck, acute heart failure, acute decompensated heart failure, SGLT2 inhibitor, renal function, biomarkerTCTR20221003002/A66